USANA Health Sciences Quick Ratio 2006-2019 | USNA

Historical quick ratio values for USANA Health Sciences (USNA) over the last 10 years.
USANA Health Sciences Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2019-12-31 $0.26B $0.14B 1.91
2019-09-30 $0.21B $0.13B 1.60
2019-06-30 $0.26B $0.13B 2.02
2019-03-31 $0.28B $0.13B 2.18
2018-12-31 $0.31B $0.15B 2.09
2018-09-30 $0.35B $0.15B 2.31
2018-06-30 $0.33B $0.14B 2.42
2018-03-31 $0.30B $0.13B 2.36
2017-12-31 $0.28B $0.14B 1.96
2017-09-30 $0.22B $0.12B 1.84
2017-06-30 $0.26B $0.14B 1.93
2017-03-31 $0.21B $0.11B 1.89
2016-12-31 $0.21B $0.14B 1.54
2016-09-30 $0.17B $0.13B 1.36
2016-06-30 $0.15B $0.13B 1.18
2016-03-31 $0.18B $0.11B 1.56
2015-12-31 $0.18B $0.13B 1.36
2015-09-30 $0.21B $0.11B 1.82
2015-06-30 $0.19B $0.11B 1.69
2015-03-31 $0.16B $0.11B 1.46
2014-12-31 $0.15B $0.11B 1.34
2014-09-30 $0.12B $0.11B 1.14
2014-06-30 $0.16B $0.09B 1.77
2014-03-31 $0.18B $0.08B 2.25
2013-12-31 $0.18B $0.10B 1.90
2013-09-30 $0.15B $0.08B 1.82
2013-06-30 $0.12B $0.08B 1.67
2013-03-31 $0.09B $0.07B 1.30
2012-12-31 $0.10B $0.07B 1.36
2012-09-30 $0.11B $0.07B 1.58
2012-06-30 $0.09B $0.07B 1.34
2012-03-31 $0.09B $0.06B 1.44
2011-12-31 $0.07B $0.06B 1.16
2011-09-30 $0.05B $0.06B 0.91
2011-06-30 $0.04B $0.05B 0.81
2011-03-31 $0.05B $0.05B 0.92
2010-12-31 $0.05B $0.06B 0.81
2010-09-30 $0.04B $0.07B 0.58
2010-06-30 $0.04B $0.04B 0.92
2010-03-31 $0.03B $0.04B 0.75
2009-12-31 $0.03B $0.04B 0.65
2009-09-30 $0.03B $0.04B 0.62
2009-06-30 $0.02B $0.04B 0.65
2009-03-31 $0.02B $0.04B 0.50
2008-12-31 $0.03B $0.06B 0.53
2008-09-30 $0.03B $0.04B 0.63
2008-06-30 $0.02B $0.04B 0.53
2008-03-31 $0.03B $0.04B 0.79
2007-12-31 $0.03B $0.05B 0.58
2007-09-30 $0.03B $0.04B 0.61
2007-06-30 $0.02B $0.08B 0.29
2007-03-31 $0.04B $0.04B 1.07
2006-12-31 $0.04B $0.04B 0.96
2006-09-30 $0.03B $0.04B 0.88
2006-06-30 $0.02B $0.03B 0.58
2006-03-31 $0.04B $0.03B 1.16
2005-12-31 $0.02B $0.03B 0.74
2005-09-30 $0.04B $0.03B 1.45
2005-06-30 $0.03B $0.03B 1.10
2005-03-31 $0.03B $0.02B 1.30
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.440B $1.061B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $64.031B 37.04
Takeda Pharmaceutical (TAK) Japan $56.514B 10.02
Astellas Pharma (ALPMY) Japan $30.561B 15.26
Eisai (ESALY) Japan $22.212B 42.82
UCB SA (UCBJF) Belgium $18.867B 0.00
Grifols, S.A (GRFS) Spain $16.845B 22.07
Merck (MKGAF) Germany $16.330B 22.28
Ono Pharmaceutical (OPHLF) Japan $11.311B 24.18
Neurocrine Biosciences (NBIX) United States $8.702B 241.77
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.449B 0.00
Catalent (CTLT) United States $8.012B 32.96
Ionis Pharmaceuticals (IONS) United States $7.779B 15.76
Jazz Pharmaceuticals (JAZZ) Ireland $7.199B 8.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.877B 0.00
Orion OYJ (ORINY) Finland $5.871B 30.12
IPSEN SA ADR (IPSEY) France $5.849B 0.00
STADA ARZNEIMI (STDAF) Germany $5.543B 0.00
Hypermarcas (HYPMY) Brazil $5.137B 15.63
United Therapeutics (UTHR) United States $4.952B 0.00
Nektar Therapeutics (NKTR) United States $3.897B 0.00
FibroGen (FGEN) United States $3.748B 110.15
Evotec AG (EVTCY) Germany $3.575B 57.69
Arrowhead Pharmaceuticals (ARWR) United States $3.468B 64.38
Sage Therapeutics (SAGE) United States $3.340B 0.00
PTC Therapeutics (PTCT) United States $3.255B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.816B 11.39
ChemoCentryx (CCXI) United States $2.692B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.020B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.945B 53.19
Xencor (XNCR) United States $1.820B 74.63
Ironwood Pharmaceuticals (IRWD) United States $1.750B 21.27
Heron Therapeutics (HRTX) United States $1.724B 0.00
Tilray (TLRY) Canada $1.665B 0.00
Corcept Therapeutics (CORT) United States $1.524B 17.05
Endo (ENDP) Ireland $1.481B 2.72
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.424B 9.71
CLINIGEN GP (CLIGF) United Kingdom $1.392B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.309B 0.00
Zogenix (ZGNX) United States $1.239B 0.00
Akebia Therapeutics (AKBA) United States $1.059B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.013B 31.40
Portola Pharmaceuticals (PTLA) United States $0.984B 0.00
Karyopharm Therapeutics (KPTI) United States $0.911B 0.00
Aerie Pharmaceuticals (AERI) United States $0.870B 0.00
Radius Health (RDUS) United States $0.826B 0.00
Collegium Pharmaceutical (COLL) United States $0.772B 0.00
ImmunoGen (IMGN) United States $0.716B 0.00
Flexion Therapeutics (FLXN) United States $0.620B 0.00
Molecular Templates (MTEM) United States $0.620B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.524B 0.00
TherapeuticsMD (TXMD) United States $0.502B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.467B 56.63
Ardelyx (ARDX) United States $0.460B 0.00
Innate Pharma SA (IPHYF) France $0.446B 0.00
Translate Bio (TBIO) United States $0.437B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.431B 18.59
Aptorum Group (APM) Hong Kong, SAR China $0.417B 0.00
Organogenesis Holdings (ORGO) United States $0.412B 0.00
Calithera Biosciences (CALA) United States $0.391B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.383B 0.00
Siga Technologies (SIGA) United States $0.375B 8.57
Indivior (INVVY) United States $0.369B 2.19
Lannett Co Inc (LCI) United States $0.363B 5.84
Rigel Pharmaceuticals (RIGL) United States $0.360B 0.00
DURECT (DRRX) United States $0.358B 0.00
Harpoon Therapeutics (HARP) United States $0.357B 0.00
Recro Pharma (REPH) United States $0.352B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.336B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.334B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.324B 0.00
Concert Pharmaceuticals (CNCE) United States $0.322B 0.00
Rafael Holdings (RFL) United States $0.309B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.302B 0.00
OptiNose (OPTN) United States $0.280B 0.00
Ocular Therapeutix (OCUL) United States $0.241B 0.00
KalVista Pharmaceuticals (KALV) United States $0.238B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.238B 0.00
MEI Pharma (MEIP) United States $0.233B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.192B 0.00
Taiwan Liposome (TLC) Taiwan $0.190B 0.00
Jounce Therapeutics (JNCE) United States $0.185B 2.48
Matinas Biopharma Holdings (MTNB) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 31.17
IMV INC (IMV) Canada $0.146B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.118B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.117B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.109B 0.00
CannTrust Holdings (CTST) Canada $0.108B 0.00
Otonomy (OTIC) United States $0.102B 0.00
Aquestive Therapeutics (AQST) United States $0.101B 0.00
Redhill Biopharma (RDHL) Israel $0.099B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.090B 0.00
Champions Oncology (CSBR) United States $0.077B 0.00
CV Sciences (CVSI) United States $0.077B 0.00
Neos Therapeutics (NEOS) United States $0.076B 0.00
Infinity Pharmaceuticals (INFI) United States $0.074B 0.00
MediWound (MDWD) Israel $0.073B 0.00
Onconova Therapeutics (ONTX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.064B 19.27
CTI BioPharma (CTIC) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
VAXART, INC (VXRT) United States $0.058B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.00
Nivalis Therapeutics (ALPN) United States $0.057B 0.00
Aclaris Therapeutics (ACRS) United States $0.057B 0.00
IsoRay (ISR) United States $0.055B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.051B 0.00
Natural Alternatives (NAII) United States $0.050B 22.81
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.046B 0.00
AgeX Therapeutics (AGE) United States $0.046B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
Forward Pharma (FWP) Denmark $0.043B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.043B 0.00
PolarityTE (PTE) United States $0.039B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.035B 0.00
Jaguar Animal Health (JAGX) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.027B 0.00
PharmAthene (ALT) United States $0.027B 0.00
Vical (BBI) United States $0.026B 0.00
China SXT Pharmaceuticals (SXTC) China $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.020B 0.00
Cardiome Pharma (CORV) Canada $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.016B 0.00
Shineco (TYHT) China $0.016B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Lipocine (LPCN) United States $0.014B 0.00
Heat Biologics (HTBX) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.013B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.013B 0.00
Novan (NOVN) United States $0.013B 0.00
HANCOCK JAFFE (HJLI) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.009B 0.00
Hemispherx BioPharma (AIM) United States $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Flex Pharma (SLRX) United States $0.004B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
RXi Pharmaceuticals (PHIO) United States $0.002B 0.00
Can-Fite Biopharma (CANF) Israel $0.002B 0.00